Target
Poly [ADP-ribose] polymerase 2
Ligand
BDBM50548677
Substrate
n/a
Meas. Tech.
ChEMBL_2022850 (CHEMBL4676663)
IC50
1.3±n/a nM
Citation
 Karche, NPBhonde, MSinha, NJana, GKukreja, GKurhade, SPJagdale, ARTilekar, ARHajare, AKJadhav, GRGupta, NRLimaye, RKhedkar, NThube, BRShaikh, JSRao Irlapati, NPhukan, SGole, GBommakanti, AKhanwalkar, HPawar, YKale, RKumar, RGupta, RPraveen Kumar, VRWahid, SFrancis, ABhat, TKamble, NPatil, VNigade, PBModi, DPawar, SNaidu, SVolam, HPagdala, VMallurwar, SGoyal, HBora, PAhirrao, PSingh, MKamalakannan, PNaik, KRKumar, PPowar, RGShankar, RBBernstein, PRGundu, JNemmani, KNarasimham, LGeorge, KSSharma, SBakhle, DKamboj, RKPalle, VP Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterization. Bioorg Med Chem 28:0 (2020) [PubMed]  Article 
Target
Name:
Poly [ADP-ribose] polymerase 2
Synonyms:
(ARTD2 or PARP2) | ADPRT2 | ADPRTL2 | PARP2 | PARP2_HUMAN | Poly [ADP-ribose] polymerase 2 (PARP-2) | Poly [ADP-ribose] polymerase 2 (PARP2)
Type:
Enzyme
Mol. Mass.:
66225.70
Organism:
Human
Description:
Q9UGN5
Residue:
583
Sequence:
MAARRRRSTGGGRARALNESKRVNNGNTAPEDSSPAKKTRRCQRQESKKMPVAGGKANKDRTEDKQDGMPGRSWASKRVSESVKALLLKGKAPVDPECTAKVGKAHVYCEGNDVYDVMLNQTNLQFNNNKYYLIQLLEDDAQRNFSVWMRWGRVGKMGQHSLVACSGNLNKAKEIFQKKFLDKTKNNWEDREKFEKVPGKYDMLQMDYATNTQDEEETKKEESLKSPLKPESQLDLRVQELIKLICNVQAMEEMMMEMKYNTKKAPLGKLTVAQIKAGYQSLKKIEDCIRAGQHGRALMEACNEFYTRIPHDFGLRTPPLIRTQKELSEKIQLLEALGDIEIAIKLVKTELQSPEHPLDQHYRNLHCALRPLDHESYEFKVISQYLQSTHAPTHSDYTMTLLDLFEVEKDGEKEAFREDLHNRMLLWHGSRMSNWVGILSHGLRIAPPEAPITGYMFGKGIYFADMSSKSANYCFASRLKNTGLLLLSEVALGQCNELLEANPKAEGLLQGKHSTKGLGKMAPSSAHFVTLNGSTVPLGPASDTGILNPDGYTLNYNEYIVYNPNQVRMRYLLKVQFNFLQLW
  
Inhibitor
Name:
BDBM50548677
Synonyms:
CHEMBL4755076
Type:
Small organic molecule
Emp. Form.:
C25H24FN5O
Mol. Mass.:
429.4894
SMILES:
Nc1cc(F)cc2c1cc([nH]c2=O)C1=C[C@@H](CC1)N1CCN(CC1)c1ccc(cc1)C#N |r,t:15|
Structure:
Search PDB for entries with ligand similarity: